VTA-100

N/A

Report date: 2023/10/18 17:51:08

Base Information

Drug NameVTA-100
Drug Alias NameVTA-100
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/Indicationsloss of tissue stem cellsRare DiseasesMuscular Dystrophies, Limb-Girdle
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVita Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCambrian Biopharma IncVita Therapeutics Inc
Inactive CompaniesN/A
Active Indicationsloss of tissue stem cellsRare DiseasesMuscular Dystrophies, Limb-Girdle
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A